Vimarsana
Biggest News Aggregation in the World

Page 38 - Stephen Evans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Evans Today - Breaking & Trending Today

Britain's long-term sickness problem is chronic – but the over-50s aren't to blame - Vimarsana News

Britain's long-term sickness problem is chronic – but the over-50s aren't to blame

Sarah has tried many times to find a job that is right for her. The 20-year-old, who lives with her father in Birmingham, has worked as a cleaner at a GP practice, a carer for the elderly and has done housekeeping and kitchen roles at a hotel.

Source: yahoo.com
NHS patient data handed to US spy tech firm Palantir in £480 million five-year deal - World News - Vimarsana News

NHS patient data handed to US spy tech firm Palantir in £480 million five-year deal - World News

Palantir, an American data handling firm headed by billionaire Republican party donor Peter Thiel, has won the biggest ever NHS outsourcing IT contract

Harper Adams University Graduate Receives Farming Life Agricultural Student of the Year 2023 Award - Vimarsana News

Harper Adams University Graduate Receives Farming Life Agricultural Student of the Year 2023 Award

Harper Adams alumnus Stephen Evans has been named the Farming Life Agricultural Student of the Year 2023.BSc (Hons) Agriculture graduate Stephen, from Fintona, Co. Tyrone, was named the winner of the prize at the Farming Life awards ceremony in Belfa

Back to Work plan slammed for threat of benefit removal - Vimarsana News

Back to Work plan slammed for threat of benefit removal

The Department for Work and Pensions has announced a ‘Back to Work’ plan to move people off the benefits system.

Concerns over informed consent for pregnant women in Pfizer's RSV vaccine trial - Vimarsana News

Concerns over informed consent for pregnant women in Pfizer's RSV vaccine trial

Some experts have criticised Pfizer for not informing pregnant women in its trial of maternal respiratory syncytial virus vaccine that trials of a similar vaccine were halted over a potential risk of preterm birth. Others think that notification would have been premature and caused unnecessary anxiety. Hristio Boytchev reports A debate has broken out over whether Pfizer should have told pregnant women participating in its trial of maternal respiratory syncytial virus (RSV) vaccination that a trial of a similar vaccine was halted over a safety signal around preterm birth, The BMJ can report. Bo...

Source: bmj.com